 |
| Cerebral Angiography Market Growth |
The global Cerebral Angiography Market is estimated to be valued at US$ 14.96 Bn in 2023 and is expected to
exhibit a CAGR of 6.1% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market Overview:
Cerebral angiography is a medical imaging technique used to visualize the
arteries in and leading to the brain and neck. It is usually performed to
identify abnormalities, such as aneurysms, arteriovenous malformations,
stenosis, etc. Cerebral angiography provides high quality images of blood
vessels in the brain and neck to enable early detection and treatment of
underlying conditions. Advantages of cerebral angiography include detection of
narrowing or blockages in blood vessels, identification of abnormal links
between arteries and veins, detection of bulging or swollen areas in blood
vessel walls called aneurysms.
Market key trends:
One of the key trends in the cerebral angiography market is the growing
adoption of flat panel detectors. Flat panel detectors are based on amorphous
silicon technology and offer better image quality as compared to image
intensifiers. Flat panel detectors provide faster imaging, higher resolution,
and more patient throughput. For example, in 2021, Siemens Healthineers launched
its Steltig C-arm system equipped with a 40x30 cm flat panel detector for
high-quality 2D and 3D imaging. Moreover, advancement in cerebral angiography
technologies such as robotic guided cerebral angiography systems is also
expected to support the growth of cerebral angiography market. Robotic guided
systems improve accuracy, efficiency and can reduce radiation exposure during
brain angiography procedures.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the Cerebral
Angiography Market Growth is low as it requires high investment for
R&D and production facilities. The market is dominated by major players.
Bargaining power of buyers: The bargaining power of buyers is moderate as
cerebral angiography procedures are not frequently required. However, the
availability of different products from various manufacturers provides options
to buyers.
Bargaining power of suppliers: The bargaining power of suppliers is low due to
the presence of many raw material suppliers. Suppliers do not have significant
influence on the overall price in the market.
Threat of new substitutes: There exists a low threat of substitutes as cerebral
angiography is mainly used for the diagnosis of brain conditions like tumors,
aneurysms and vascular malformations.
Competitive rivalry: High due to the presence of few large players dominating
the market.
Key Takeaways
The global cerebral angiography market is expected to witness high growth,
exhibiting a CAGR of 6.1% over the
forecast period, due to increasing incidence of brain aneurysms and rising
geriatric population.
Regional analysis: North America dominates the global cerebral angiography
market aided by presence of major market players, developed healthcare
infrastructure and technological advancements. Asia Pacific is expected to
exhibit the fastest growth rate over the forecast period owing to increasing
healthcare expenditure and rising awareness regarding brain conditions.
Key players operating in the cerebral angiography market are Siemens
Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems
Corporation, Shimadzu Corporation, Hitachi, Ltd., Carestream Health, Inc.,
Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific
Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific
Corporation, Cook Medical LLC. Key players focus on new product launches,
partnerships and regional expansions to consolidate their market position.
Read More: https://www.trendingwebwire.com/cerebral-angiography-market-witness-high-growth/